Biotechnology
Access to abortion pill mifepristone at stake in federal appeals court hearing
Mifepristone, the first medication in a medical abortion, is prepared for a patient at Alamo Women’s Clinic in Carbondale, Illinois, April 20, 2023. Evelyn Hockstein | Reuters A federal appeals court will hear arguments Wednesday afternoon in a closely watched lawsuit that seeks to pull the abortion pill mifepristone from the U.S. market. The hearing […]
Read More
Pfizer RSV vaccine for infants has ‘generally favorable’ safety data, FDA staff say
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer’s vaccine that protects infants from respiratory syncytial virus has “generally favorable” safety data. The FDA staff made the conclusion in briefing documents ahead of a meeting on Thursday, when a panel […]
Read More
Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
Robert Galbraith | Reuters Horizon Therapeutics‘ stock price plunged more than 17% in premarket trading Tuesday after a report that the Federal Trade Commission is preparing to file a lawsuit to block the biotech company’s $27.8 billion sale to Amgen. The FTC could sue to block the acquisition as soon as Tuesday, Bloomberg reported, citing […]
Read More
Google Cloud launches A.I.-driven resources to accelerate drug discovery, precision medication
A particular person walks upcoming to the Google Cloud symbol at the Mobile Globe Congress (MWC) in Barcelona, Spain February 27, 2023. Nacho Doce | Reuters Google Cloud on Tuesday introduced two new AI-run instruments that intention to help biotech and pharmaceutical companies speed up drug discovery and progress precision medication. One resource, identified as […]
Read More
Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health
A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters Patients are now enrolling in an early stage clinical trial to test a universal flu vaccine based on messenger RNA technology, the National Institutes of Health announced Monday. […]
Read More
Biden to nominate cancer surgeon Monica Bertagnolli to lead National Institutes of Health
Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. Jeff Chiu | AP President Joe Biden will nominate Dr. Monica Bertagnolli, a cancer surgeon, to lead the National Institutes of Health, the […]
Read More
Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | Reuters The new Alzheimer’s antibody treatment Leqembi could cost Medicare up to $5 billion per year, according to research published in a leading medical journal this week. Medicare would spend about $2 billion per year […]
Read More
Americans in most states will no longer receive Covid exposure notifications on phones
Americans in most states will no longer receive Covid exposure notifications on their smartphones now that the U.S. public health emergency has ended. Since 2020, nearly 30 states have used a Bluetooth system developed by Apple and Google to track the spread of Covid infections and send push alerts to any smartphone user who came […]
Read More
Here’s why Covid vaccines will still be free for uninsured Americans as public health emergency ends
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Uninsured Americans can still access Covid-19 vaccines at no cost, for now, even though the U.S. public health emergency has […]
Read More
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla on Thursday said pharmaceutical companies […]
Read More